XML 19 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance at Dec. 31, 2020 $ 1,172 $ 68,987,663 $ (63,193,707) $ 5,795,128
Beginning balance, shares at Dec. 31, 2020 11,725,764      
Issuance of restricted stock
Issuance of restricted stock, shares 1,200      
Common stock issued in connection of the acquisition of SuperFit Foods on March 25, 2021 $ 27 624,973 625,000
Common stock issued in connection of the acquisition of SuperFit Foods on March 25, 2021, shares 268,240      
Common stock, pre-funded warrants and warrants issued in private placement on April 7, 2021, net of fees $790,000 $ 125 9,181,224 9,181,349
Common stock, pre-funded warrants and warrant issued in private placement on April 7, 2021, shares 1,250,000      
Common stock issued in connection of the acquisition of Pokemoto on May 14, 2021 $ 88 1,249,912 1,250,000
Common stock issued in connection of the acquisition of Pokemoto on May 14, 2021, shares 880,282      
Common stock, pre-funded warrants and warrants issued in private placement on November 22, 2021, net of fees $1,289,965 $ 677 13,708,924 13,709,601
Common stock, pre-funded warrants and warrant issued in private placement on November 22, 2021, shares 6,772,000      
Reconciliation for shares outstanding per transfer agent $ 22 636,495 636,517
Reconciliation for shares outstanding per transfer agent,shares 221,783      
Common stock issued as compensation to board of directors $ 7 114,029 114,036
Common stock issued as compensation to board of directors, shares 73,941      
Common stock issued as compensation for services $ 86 1,326,941 1,327,027
Common stock issued as compensation for services, shares 852,500      
Exercise of pre-funded warrants $ 408 28,365 28,773
Exercise of pre-funded warrants, shares 4,075,337      
Cancellation of share per agreement with shareholder $ (1) (99,999) (100,000)
Cancellation of share per agreement with shareholder,Shares (11,879)      
Common stock issued to investor 1,540 1,540
Common stock issued to investor, shares 1,100      
Amortization of restricted common stock 426 426
Net loss (8,176,130) (8,176,130)
Ending balance at Dec. 31, 2021 $ 2,611 95,760,493 (71,369,837) 24,393,267
Ending balance, shares at Dec. 31, 2021 26,110,268      
Reconciliation for shares outstanding per transfer agent
Reconciliation for shares outstanding per transfer agent,shares 30,910      
Common stock issued as compensation to board of directors $ 24 113,952 113,976
Common stock issued as compensation to board of directors, shares 243,345      
Common stock issued as compensation for services $ 7 17,545 17,552
Common stock issued as compensation for services, shares 35,000      
Exercise of pre-funded warrants $ 44 44
Exercise of pre-funded warrants, shares 438,085      
Net loss (7,962,428) (7,962,428)
Cumulative effect of change in accounting principal (22,799) (22,799)
Cash less exercise of pre-funded warrants $ 241 (241)
Cashless exercise of pre-funded warrants shares 2,409,604      
Common stock issued as compensation for employment $ 2 10,798 10,800
Common stock issued as compensation to employment, shares 20,000      
Stock-based compensation – options 10,600 10,600
Ending balance at Dec. 31, 2022 $ 2,929 $ 95,913,147 $ (79,355,064) $ 16,561,012
Ending balance, shares at Dec. 31, 2022 29,287,212